CONTINUE TO SITE

OR WAIT null SECS

Biochemical Recurrence in Prostate Cancer Lung Cancer Quiz NCCN Guidelines Update for HR+ Breast Cancer Register: Duration of Therapy in Multiple Myeloma: Decision-Making and Clinical Impact Updates in the Management of Extensive-Stage Small Cell Lung Cancer

Biochemical Recurrence in Prostate Cancer Lung Cancer QuizNCCN Guidelines Update for HR+ Breast CancerRegister: Duration of Therapy in Multiple Myeloma: Decision-Making and Clinical ImpactUpdates in the Management of Extensive-Stage Small Cell Lung Cancer

Clinical

View More Brain Cancer Breast Cancer Colorectal Cancer Gastrointestinal Cancer Genitourinary Cancer Gynecologic Cancer Hematology Leukemia Lung Cancer Lymphoma Pediatric Cancers Skin Cancer

Brain CancerBreast CancerColorectal CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHematologyLeukemiaLung CancerLymphomaPediatric CancersSkin Cancer

News

All News NP/PA Practice Management Technology

All NewsNP/PAPractice ManagementTechnology

Media

Around the Practice Between the Lines Clinical Consult Enduring Webinars Expert Interviews Medical World News OncView Podcasts Readout 360 Tumor Board Series

Around the PracticeBetween the LinesClinical ConsultEnduring WebinarsExpert InterviewsMedical World NewsOncViewPodcastsReadout 360Tumor Board Series

Conferences

Publications

About Oncology Journal MBCC Abstract Supplement Oncology Journal

About Oncology JournalMBCC Abstract SupplementOncology Journal

Events

Live Events Virtual Events

Live EventsVirtual Events

CME/CE

Resources

Image IQ Partners Polls Quizzes Slideshows Sponsored Toolkits Tumor Board

Image IQPartnersPollsQuizzesSlideshowsSponsoredToolkitsTumor Board

eNewsletter Print Subscription

eNewsletterPrint Subscription

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Spotlight

Biochemical Recurrence in Prostate Cancer
Lung Cancer Quiz
NCCN Guidelines Update for HR+ Breast Cancer
Register: Duration of Therapy in Multiple Myeloma: Decision-Making and Clinical Impact
Updates in the Management of Extensive-Stage Small Cell Lung Cancer

ClinicalSee All >

Brain Cancer
Breast Cancer
Colorectal Cancer
Gastrointestinal Cancer
Genitourinary Cancer
Gynecologic Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Pediatric Cancers
Skin Cancer

CureToday.com
OncLive.com
TargetedOnc.com
Contact
Terms and Conditions
Privacy
Do Not Sell My Personal Information

Jerome M. Butler, MD | Authors

DERMATOLOGY & SKIN CARE ASSOCIATES LLC

5160 SOCIALVILLE FOSTER RD

Articles

Irinotecan/Gemcitabine Followed by Twice-Weekly Gemcitabine/Radiation in Locally Advanced Pancreatic Cancer

May 02, 2002

Early clinical studies combining irinotecan (CPT-11, Camptosar) and gemcitabine (Gemzar) have yielded encouraging results. Gemcitabine administered via a twice-weekly schedule results in an enhanced radiation-sensitizing effect.